# Previous ChapterChapter 5: Pricing and Reimbursement Issues in Neurology Next Chapter

Chapter 5: Pricing and Reimbursement Issues in Neurology

Pricing and Reimbursement Issues in Neurology
Pricing and reimbursement issues in neurology
Introduction

Neurological disorders are common and highly disabling conditions that will impose a growing burden on aging societies in industrialized nations. We estimate that, in the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan alone, the number of people afflicted with Alzheimer's disease, epilepsy, multiple sclerosis, and Parkinson's disease will increase from approximately 15 million in 2005 to 17 million in 2015. Spending on drug therapies for these four disorders will grow even faster, increasing from $11 billion in 2005 to$18 billion in 2015.

The size of this market is attributable in part to high drug prices, especially in the United States. The rising cost of routine poly-therapy and long-term use of ...